135 related articles for article (PubMed ID: 7093103)
1. Elimination kinetics of labetalol in severe renal failure.
Wood AJ; Ferry DG; Bailey RR
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):81S-86S. PubMed ID: 7093103
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
Elliott HL; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of labetalol.
McNeil JJ; Louis WJ
Clin Pharmacokinet; 1984; 9(2):157-67. PubMed ID: 6370541
[TBL] [Abstract][Full Text] [Related]
4. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of labetalol increases with age.
Kelly JG; McGarry K; O'Malley K; O'Brien ET
Br J Clin Pharmacol; 1982 Aug; 14(2):304-5. PubMed ID: 7104187
[TBL] [Abstract][Full Text] [Related]
6. The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1984 Sep; 18(3):393-400. PubMed ID: 6487478
[TBL] [Abstract][Full Text] [Related]
7. Decreased first-pass metabolism of labetalol in chronic liver disease.
Homeida M; Jackson L; Roberts CJ
Br Med J; 1978 Oct; 2(6144):1048-50. PubMed ID: 709214
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pharmacokinetics of labetalol in healthy young men.
Nyberg G; Hansson R; Tietz F
Acta Med Scand Suppl; 1982; 665():67-73. PubMed ID: 6961762
[TBL] [Abstract][Full Text] [Related]
9. Labetalol disposition and concentration-effect relationships during pregnancy.
Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of labetalol in healthy volunteers.
Kanto J; Allonen H; Kleimola T; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):41-4. PubMed ID: 7203731
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of dilevalol in renal impairment.
Kelly JG; Laher MS; Donohue J; Doyle GD
J Hum Hypertens; 1990 Jun; 4 Suppl 2():59-62. PubMed ID: 2370645
[TBL] [Abstract][Full Text] [Related]
13. Effect of food on the bioavailability of labetalol.
Mäntylä R; Allonen H; Kanto J; Kleimola T; Sellman R
Br J Clin Pharmacol; 1980 Apr; 9(4):435-7. PubMed ID: 7378263
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
Sanders GL; Davies DM; Rawlins MD
Br J Clin Pharmacol; 1980 Aug; 10(2):121-6. PubMed ID: 6252915
[TBL] [Abstract][Full Text] [Related]
15. Ofloxacin pharmacokinetics in renal failure.
Fillastre JP; Leroy A; Humbert G
Antimicrob Agents Chemother; 1987 Feb; 31(2):156-60. PubMed ID: 3471179
[TBL] [Abstract][Full Text] [Related]
16. Improved liquid-chromatographic assay of labetalol in plasma.
Luke DR; Matzke GR; Clarkson JT; Awni WM
Clin Chem; 1987 Aug; 33(8):1450-2. PubMed ID: 3608164
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
Rasmussen S; Nielsen PE
Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
[TBL] [Abstract][Full Text] [Related]
18. Tinidazole pharmacokinetics in severe renal failure.
Robson RA; Bailey RR; Sharman JR
Clin Pharmacokinet; 1984; 9(1):88-94. PubMed ID: 6692632
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
[TBL] [Abstract][Full Text] [Related]
20. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
